ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Management of basal cell carcinoma at low risk of recurrence

Management of basal cell carcinoma at low risk of recurrence
BCC: basal cell carcinoma.
* Low-risk primary BCC:[1]
  • Well-defined, primary BCC <20 mm located on trunk or extremities (excluding genitalia, pretibia, hands, and feet).
  • Histopathologically nodular or superficial histopathologic growth pattern, other nonaggressive growth patterns (infundibulocystic, fibroepithelioma of Pinkus). Lack of perineural invasion.
  • No history of radiation therapy at site.
  • Immunocompetent patient.
¶ Recurrent BCC following treatment with topical therapies or photodynamic therapy are considered high-risk tumors. These lesions are best treated with conventional re-excision or Mohs surgery. Refer to UpToDate topics on the management of BCC at high risk of recurrence for additional information.
Δ Radiation therapy is not indicated in patients <60 years because of risk of long-term, local complications and in patients with genetic syndromes predisposing to skin cancers (eg, Gorlin syndrome, xeroderma pigmentosum).
In patients with multiple medical comorbidities or an anticipated limited lifespan, close clinical follow-up for a slow-growing, low-risk BCC may be a reasonable option.
Reference:
  1. National Comprehensive Cancer Network (NCCN) Guidelines in Oncology: Basal Cell Skin Cancer. Version 2.2021. Available at: https://www.nccn.org (Accessed on November 1, 2021).
Graphic 134415 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟